DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,075,362 | +24.2% | 12,396 | +20.1% | 0.14% | +23.9% |
| Q2 2023 | $2,476,760 | -2.6% | 10,320 | +2.3% | 0.11% | -7.4% |
| Q1 2023 | $2,543,259 | -9.9% | 10,091 | -5.2% | 0.12% | -21.3% |
| Q4 2022 | $2,823,987 | +26.5% | 10,640 | +23.1% | 0.16% | +9.2% |
| Q3 2022 | $2,233,000 | +5.4% | 8,644 | +3.5% | 0.14% | +6.8% |
| Q2 2022 | $2,118,000 | -11.6% | 8,353 | +2.3% | 0.13% | +9.0% |
| Q1 2022 | $2,396,000 | -5.7% | 8,167 | +5.7% | 0.12% | -11.6% |
| Q4 2021 | $2,542,000 | +9.6% | 7,727 | +1.4% | 0.14% | +3.8% |
| Q3 2021 | $2,320,000 | +16.9% | 7,620 | +3.1% | 0.13% | +10.8% |
| Q2 2021 | $1,984,000 | -25.4% | 7,394 | -37.4% | 0.12% | -2.4% |
| Q1 2021 | $2,658,000 | -1.6% | 11,807 | -2.9% | 0.12% | -11.5% |
| Q4 2020 | $2,700,000 | +64.2% | 12,155 | +59.2% | 0.14% | -3.5% |
| Q3 2020 | $1,644,000 | +21.3% | 7,636 | -0.4% | 0.14% | +17.1% |
| Q2 2020 | $1,355,000 | +23.1% | 7,665 | +1.5% | 0.12% | +5.1% |
| Q1 2020 | $1,101,000 | +6.1% | 7,555 | +11.7% | 0.12% | +15.8% |
| Q4 2019 | $1,038,000 | +15.7% | 6,764 | +8.9% | 0.10% | +2.0% |
| Q3 2019 | $897,000 | +3.8% | 6,212 | +2.8% | 0.10% | 0.0% |
| Q2 2019 | $864,000 | -5.2% | 6,045 | -12.4% | 0.10% | -10.8% |
| Q1 2019 | $911,000 | +33.4% | 6,902 | +4.2% | 0.11% | +15.6% |
| Q4 2018 | $683,000 | +3.0% | 6,624 | -0.7% | 0.10% | +6.7% |
| Q3 2018 | $663,000 | +8.9% | 6,673 | +9.4% | 0.09% | +5.9% |
| Q2 2018 | $609,000 | +3.9% | 6,102 | +2.0% | 0.08% | -9.6% |
| Q1 2018 | $586,000 | +11.0% | 5,980 | +5.2% | 0.09% | +8.0% |
| Q4 2017 | $528,000 | +12.6% | 5,684 | +4.0% | 0.09% | -17.9% |
| Q3 2017 | $469,000 | – | 5,468 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |